Uncategorised - European Medical Journal

Physical Activity Reduces Exacerbations in COPD Patients on Dual Bronchodilators

Regular physical activity reduces exacerbations in COPD patients using dual bronchodilators, study finds.

Reduced Hippocampal Iron Accelerates Cognitive Decline in Alzheimer’s Disease

A randomised clinical trial found that lowering levels of iron in the brain using deferiprone may accelerate cognitive decline in patients with early-stage Alzheimer’s disease

Low Prevalence of Serious Cardiovascular Events in CAR T-Cell Therapy Recipients

A recent meta-analysis investigating cardiovascular complications in adults undergoing chimeric antigen receptor (CAR) T-cell therapy for advanced hematologic cancers has revealed reassuring findings.

Stem-Cell Therapy Success in China Marks Milestone in Type 1 Diabetes Treatment

25-year-old woman with Type 1 diabetes in China has successfully undergone a stem-cell therapy that enabled her to produce her own insulin, reducing her reliance on injections.

Study Reveals Growing Antibiotic Resistance in Atopic Dermatitis

A recent systematic review and meta-analysis highlights concerns about antibiotic resistance in Staphylococcus aureus strains found in individuals with atopic dermatitis.

Once-Weekly Semaglutide: Relief for Knee Pain?

In a groundbreaking study, once-weekly semaglutide injections were shown to significantly reduce both knee osteoarthritis pain and body weight in adults with obesity, offering promising new relief for patients with limited treatment options.

Unequal Insurance Coverage Worsens Cancer Outcomes

A powerful link between health insurance status and racial and ethnic disparities in advanced cancer diagnoses has been identified in a recently published study.

Emerging Evidence for Laser Hair Removal in Treating Hidradenitis Suppurativa

New evidence highlights the potential of laser hair removal and intense pulsed light (IPL) therapy in reducing lesion count and flare-ups for patients with hidradenitis suppurativa (HS).

FDA Proposes OTC Ban for Oral Phenylephrine

The FDA has announced it is proposing removing oral phenylephrine from the list of over-the-counter (OTC) nasal decongestant ingredients due to extensive evidence questioning its effectiveness.

Resisting the Resistance: Experts versus Superbugs

They outline the current state of the fight against antimicrobial resistance (AMR), discussing the latest developments in prevention…